Product image of Nephromag (Mertiatide) supplied by GNH India

Nephromag

Active Ingredient:
Mertiatide
Origin:
EU

Nephromag (Mertiatide)

Mertiatide, the active ingredient in Nephromag, is an investigational compound presented as an intravenous formulation for parenteral use. It is being evaluated for potential therapeutic applications in renal and transplant medicine. Current data are limited and it is not yet approved for specific indications.

GNH India supplies Nephromag as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide. The company adheres to stringent quality standards and provides regulatory support for global distribution.

Manufacturer / TM Owner

Rotop Pharmaka Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nephromag (Mertiatide) is an investigational agent studied in renal and transplant‑related pathways.

  • No approved indication: currently under clinical investigation for renal transplantation.
  • No approved indication: currently under clinical investigation for acute kidney injury.
  • No approved indication: currently under clinical investigation for chronic kidney disease.

How It Works

  • The precise mechanism of Mertiatide has not been disclosed in publicly available literature. It is presumed to interact with renal cellular pathways, but detailed pharmacodynamic data are lacking, and the exact molecular targets remain undefined.

Side Effects

Adverse reactions have not been comprehensively documented for Mertiatide.

Common Side Effects

  • None reported: no data available.
  • None reported: no data available.

Serious or Rare Side Effects

  • None reported: no data available.
  • None reported: no data available.

Precautions & Warnings

Given the limited safety information, careful clinical monitoring is advised.

  • Clinical monitoring: observe patients closely for any unexpected reactions.
  • Pregnancy: safety not established; avoid unless benefits outweigh risks.
  • Renal function: assess baseline function before administration.
  • Allergy: discontinue if hypersensitivity signs appear.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Avoid Interactions

Potential drug interactions have not been fully characterized.

Major Interactions (Avoid)

  • None reported: no known major drug interactions.

Moderate Interactions (Monitor Closely)

  • Potential interaction with nephrotoxic agents: monitor renal function.
  • Concurrent use with immunosuppressants: observe for additive immunosuppression.
  • Co‑administration with anticoagulants: watch for altered bleeding risk.
  • Interaction with contrast media: assess renal impact.

Frequently Asked Questions

Nephromag contains the investigational compound Mertiatide and is being studied for potential use in renal transplantation, acute kidney injury, and chronic kidney disease. No specific therapeutic indication has been approved.

The exact mechanism of Mertiatide is not publicly disclosed. It is thought to interact with renal cellular pathways, but detailed pharmacological targets and actions remain undefined.

Dosing of Nephromag is determined by the prescribing clinician based on the specific investigational protocol or clinical judgment. No standardized dosing regimen is publicly available.

Safety of Mertiatide in pregnancy or lactation has not been established. It should be avoided unless the potential benefit justifies the potential risk to the fetus or infant.

Enquiries can be submitted on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and import documentation.

Because Mertiatide is still investigational, direct comparative data with established renal agents are limited. Existing therapies have well‑characterized efficacy and safety profiles, whereas Nephromag’s benefits and risks are still being evaluated in clinical studies.

Nephromag should be stored at 2‑8 °C, kept refrigerated, protected from light, and must not be frozen or shaken. Follow all cold‑chain handling procedures during transport and storage.

Nephromag is supplied for intravenous administration. It is infused by a qualified healthcare professional according to the protocol prescribed by the treating physician.

Serious risks have not been fully defined due to limited data. Clinicians should monitor for unexpected adverse reactions, especially hypersensitivity, renal function changes, and any signs of infection or immunosuppression.

Patients with known hypersensitivity to Mertiatide or any excipients, those with uncontrolled renal impairment, and individuals for whom the safety of the drug has not been established (e.g., pregnant or breastfeeding women) should not receive Nephromag unless a specialist determines a clear benefit.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mertiatide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT